|
|
| 总数集(n = 67) | 训练集(n = 44) | 验证集(n = 23) |
| 年龄(年) |
| 62.43 ± 8.56 | 62.45 ± 8.22 | 62.39 ± 9.38 |
| 肿瘤最大径(cm) |
| 3.32 ± 1.44 | 3.35 ± 1.49 | 3.24 ± 1.38 |
| 术前BMI (kg/m2) |
| 22.66 ± 3.17 | 22.25 ± 2.92 | 23.43 ± 3.53 |
| 术前胆固醇(mmol/L) |
| 5.00 ± 0.96 | 4.99 ± 0.99 | 5.04 ± 0.93 |
| 术前淋巴细胞计数(109/L) |
| 1.84 [1.36, 2.33] | 1.85 [1.39, 2.34] | 1.78 [1.33, 2.32] |
| 术前白蛋白(mmol/L) |
| 38.24 [36.00, 41.52] | 37.97 [35.88, 40.59] | 38.82 [36.80, 43.02] |
| 空腹血糖(mmol/L) |
| 4.72 [4.16, 5.47] | 4.70 [4.10, 5.46] | 4.91 [4.34, 5.43] |
| 术前甘油三酯(mmol/L) |
| 0.99 [0.86, 1.31] | 1.01 [0.85, 1.35] | 0.99 [0.88, 1.12] |
| PPR |
| 0.93 [0.87, 1.00] | 0.97 [0.87, 1.00] | 0.88 [0.86, 0.98] |
| 生存时间(月) |
| 28.00 [15.00, 40.00] | 26.00 [16.50, 40.50] | 32.00 [14.50, 39.00] |
| 生存结局(%) | 存活 | 45 (67.2) | 30 (68.2) | 15 (65.2) |
| 死亡 | 22 (32.8) | 14 (31.8) | 8 (34.8) | |
| 性别(%) | 男 | 65 (97.0) | 43 (97.7) | 22 (95.7) |
| 女 | 2 (3.0) | 1 (2.3) | 1 (4.3) | |
| TNM分期(%) | I期 | 16 (23.9) | 8 (18.2) | 8 (34.8) |
| II期 | 24 (35.8) | 19 (43.2) | 5 (21.7) | |
| III期 | 20 (29.9) | 13 (29.5) | 7 (30.4) | |
| IV期 | 7 (10.4) | 4 (9.1) | 3 (13.0) | |
| 是否放化疗(%) | 否 | 26 (38.8) | 18 (40.9) | 8 (34.8) |
| 是 | 41 (61.2) | 26 (59.1) | 15 (65.2) | |
| 腹部手术史(%) | 无 | 57 (85.1) | 38 (86.4) | 19 (82.6) |
| 有 | 10 (14.9) | 6 (13.6) | 4 (17.4) |